List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 86 studies with search of:   "Dacarbazine"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Trial of Dacarbazine With or Without Genasense in Advanced Melanoma
Condition: Melanoma
Interventions: Drug: dacarbazine plus Genasense;   Drug: dacarbazine plus placebo
2 Active, not recruiting Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma
Condition: Melanoma
Interventions: Drug: Ipilimumab and Dacarbazine;   Drug: Placebo and Dacarbazine
3 Recruiting Safety Study of Combined Chemotherapy and Endostar to Untreated Patients With Advanced Melanoma
Conditions: Advanced Melanoma;   Untreated Patients
Interventions: Drug: dacarbazine plus Endostar (Experimental group);   Drug: dacarbazine plus placebo (control group)
4 Recruiting Trial of PI-88 With Dacarbazine in Patients With Metastatic Melanoma
Condition: Melanoma
Interventions: Drug: PI-88 and dacarbazine;   Drug: dacarbazine or DTIC
5 Completed Temozolomide Versus Dacarbazine in Stage IV Metastatic Melanoma (Study P03267AM2)(COMPLETED)
Condition: Melanoma
Interventions: Drug: Temozolomide;   Drug: Dacarbazine
6 Recruiting Adjuvant, Combined Interleukin 2 (Proleukin) and DTIC (Dacarbazine) in High-Risk Melanoma Patients
Condition: Metastatic Melanoma
Intervention: Drug: Proleukin and Dacarbazine
7 Recruiting Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma
Conditions: Melanoma;   Soft Tissue Sarcoma;   Parathyroid Carcinoma;   Small Cell Carcinoma of the Lung;   Carcinoid Tumors
Intervention: Drug: Dacarbazine and bortezomib
8 Active, not recruiting A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of PARP in Combination With Dacarbazine
Condition: Melanoma Neoplasms
Interventions: Drug: KU-0059436 (AZD2281)(PARP inhibitor);   Drug: dacarbazine
9 Active, not recruiting Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma
Conditions: Solid Tumor;   Thyroid Cancer
Interventions: Drug: Capecitabine;   Drug: Dacarbazine;   Drug: Imatinib
10 Completed Lenalidomide and Dacarbazine (DTIC) in Patients With Metastatic Melanoma
Condition: Melanoma
Interventions: Drug: Lenalidomide;   Drug: Dacarbazine
11 Recruiting A Phase I/II Study of Dasatinib and Dacarbazine
Condition: Metastatic Melanoma
Intervention: Drug: Dasatinib and Dacarbazine
12 Recruiting A Phase I/II Study of Sunitinib and Dacarbazine
Condition: Melanoma
Interventions: Drug: Sunitinib;   Drug: Dacarbazine (DTIC)
13 Not yet recruiting Dacarbazine for Metastatic Soft Tissue and Bone Sarcoma
Condition: Sarcoma
Intervention: Drug: dacarbazine
14 Completed Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma
Conditions: Stage IV Melanoma;   Stage III Melanoma;   Recurrent Melanoma
Interventions: Drug: allovectin-7;   Drug: allovectin-7/dacarbazine;   Drug: dacarbazine
15 Active, not recruiting Dacarbazine With or Without Oblimersen (G3139) in Treating Patients With Advanced Malignant Melanoma
Condition: Melanoma (Skin)
Interventions: Drug: dacarbazine;   Drug: oblimersen
16 Active, not recruiting Phase 3 Trial of CP-675,206 Versus Either Dacarbazine or Temozolomide in Patients Without Prior Therapy
Condition: Melanoma
Interventions: Drug: dacarbazine or temozolomide (choice);   Drug: CP-675,206
17 Recruiting Phase II R-ABVD Versus ABVD for Advanced Stage Classical Hodgkin Lymphoma
Condition: Hodgkin Lymphoma
Interventions: Drug: Rituximab;   Drug: Adriamycin;   Drug: Bleomycin;   Drug: Vinblastine;   Drug: Dacarbazine
18 Active, not recruiting Temozolomide or Dacarbazine in Treating Patients With Stage IV Melanoma
Condition: Melanoma (Skin)
Interventions: Drug: dacarbazine;   Drug: temozolomide
19 Active, not recruiting Oblimersen and Dacarbazine in Treating Patients With Advanced Malignant Melanoma That Has Responded to Treatment on Clinical Trial GENTA-GM301
Condition: Melanoma (Skin)
Interventions: Drug: dacarbazine;   Drug: oblimersen
20 Completed Evaluating The Antitumor Activity Of MEDI-522 With Or Without Dacarbazine In Patients With Metastatic Melanoma
Conditions: Melanoma;   Malignant Metastatic Melanoma
Interventions: Biological: MEDI--522;   Biological: Integrin + Dacarbazine

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services